According to the World Health Organization, pharmacovigilance (also known as drug safety) is ’the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem’. As such, it plays a pivotal role in ensuring public health, monitoring the risks associated to the use of medicinal products and mitigating their heavy consequences on morbidity and mortality.
Over the past 20 years, pharmacovigilance has evolved from a reactive, regulatory-driven activity into a proactive and highly sophisticated discipline aimed at preventing - rather than merely managing - potential safety issues. This evolution got new momentum with the
EU pharmacovigilance legislation rolled out in 2012, nevertheless knowing by heart the letter of existing regulations is not a substitute for experience and sound medical/scientific judgment.
This is why Saphar employs seasoned drug safety professionals to provide world-class support to small
& large organizations looking for a tailored, effective and scalable solution to their pharmacovigilance needs in Europe.